标题
Tumor Microenvironment in Diffuse Large B-Cell Lymphoma: Role and Prognosis
作者
关键词
-
出版物
Analytical Cellular Pathology
Volume 2019, Issue -, Pages 1-9
出版商
Hindawi Limited
发表日期
2019-12-17
DOI
10.1155/2019/8586354
参考文献
相关参考文献
注意:仅列出部分参考文献,下载原文获取全部文献信息。- Dissection of DLBCL microenvironment provides a gene expression-based predictor of survival applicable to formalin-fixed paraffin-embedded tissue
- (2018) S Ciavarella et al. ANNALS OF ONCOLOGY
- Integrating genomic alterations in diffuse large B-cell lymphoma identifies new relevant pathways and potential therapeutic targets
- (2017) K Karube et al. LEUKEMIA
- The expression and clinical relevance of PD-1, PD-L1, and TP63 in patients with diffuse large B-cell lymphoma
- (2017) Xia Fang et al. MEDICINE
- Significance of stromal-1 and stromal-2 signatures and biologic prognostic model in diffuse large B-cell lymphoma
- (2017) Asmaa Gaber Abdou et al. Cancer Biology & Medicine
- RelA NF-κB subunit activation as a therapeutic target in diffuse large B-cell lymphoma
- (2016) Mingzhi Zhang et al. Aging-US
- Prognostic Impact of Tumor Microenvironment in Diffuse Large B-Cell Lymphoma Uniformly Treated With R-CHOP Chemotherapy
- (2016) Juan C. Gomez-Gelvez et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Tumor microenvironment in diffuse large B-cell lymphoma: Matrixmetalloproteinases activation is mediated by osteopontin overexpression
- (2016) Grazia Malaponte et al. BIOCHIMICA ET BIOPHYSICA ACTA-MOLECULAR CELL RESEARCH
- Prognostic value of expression of nuclear factor kappa-B/p65 in non-GCB DLBCL patients
- (2016) Jing Wang et al. Oncotarget
- PD-L1 expression in EBV-negative diffuse large B-cell lymphoma: clinicopathologic features and prognostic implications
- (2016) Wei Xing et al. Oncotarget
- M2 tumour-associated macrophages contribute to tumour progression via legumain remodelling the extracellular matrix in diffuse large B cell lymphoma
- (2016) Long Shen et al. Scientific Reports
- Expression of programmed cell death ligand 1 is associated with poor overall survival in patients with diffuse large B-cell lymphoma
- (2015) J. Kiyasu et al. BLOOD
- Clinicopathological implications of nuclear factor κB signal pathway activation in diffuse large B-cell lymphoma
- (2015) Qian Zhao et al. HUMAN PATHOLOGY
- Lymphomagenic CARD11/BCL10/MALT1 signaling drives malignant B-cell proliferation via cooperative NF-κB and JNK activation
- (2015) Nathalie Knies et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Are the High Serum Interleukin-6 and Vascular Endothelial Growth Factor Levels Useful Prognostic Markers in Aggressive Non-Hodgkin Lymphoma Patients?
- (2015) Hava Üsküdar Teke et al. Turkish Journal of Hematology
- Prognostic impact of c-Rel nuclear expression and REL amplification and crosstalk between c-Rel and the p53 pathway in diffuse large B-cell lymphoma
- (2015) Ling Li et al. Oncotarget
- Aberrant Promoter Methylation of Sparc in Ovarian Cancer
- (2015) Matthew J. Socha et al. NEOPLASIA
- Expression patterns of stromal MMP-2 and tumoural MMP-2 and -9 are significant prognostic factors in invasive ductal carcinoma of the breast
- (2014) Kyueng-Whan Min et al. APMIS
- Genomic rearrangements involving programmed death ligands are recurrent in primary mediastinal large B-cell lymphoma
- (2014) David D. W. Twa et al. BLOOD
- Diffuse large B-cell lymphoma: optimizing outcome in the context of clinical and biologic heterogeneity
- (2014) Laurie H. Sehn et al. BLOOD
- Determining cell-of-origin subtypes of diffuse large B-cell lymphoma using gene expression in formalin-fixed paraffin-embedded tissue
- (2014) D. W. Scott et al. BLOOD
- Prognostic influence of macrophages in patients with diffuse large B-cell lymphoma: a correlative study from a Nordic phase II trial
- (2014) S. Riihijarvi et al. HAEMATOLOGICA
- High density of CD68+/CD163+ tumour-associated macrophages (M2-TAM) at diagnosis is significantly correlated to unfavorable prognostic factors and to poor clinical outcomes in patients with diffuse large B-cell lymphoma
- (2014) Francesco Marchesi et al. HEMATOLOGICAL ONCOLOGY
- CD14+HLA-DR low/−monocytes as indicator of disease aggressiveness in B-cell non-Hodgkin lymphoma
- (2014) K. A. Khalifa et al. International Journal of Laboratory Hematology
- An increase of M2 macrophages predicts poor prognosis in patients with diffuse large B-cell lymphoma treated with rituximab, cyclophosphamide, doxorubicin, vincristine and prednisone
- (2014) Soo Jeong Nam et al. LEUKEMIA & LYMPHOMA
- Microvascular density, CD68 and tryptase expression in human Diffuse Large B-Cell Lymphoma
- (2014) Christian Marinaccio et al. LEUKEMIA RESEARCH
- Expression of PD-1 (CD279) and FoxP3 in diffuse large B-cell lymphoma
- (2014) Matthew J. Ahearne et al. VIRCHOWS ARCHIV
- Matrix metalloproteinase-9 overexpression is closely related to poor prognosis in patients with colon cancer
- (2014) Bo Yang et al. World Journal of Surgical Oncology
- Legumain protease-activated TAT-liposome cargo for targeting tumours and their microenvironment
- (2014) Ze Liu et al. Nature Communications
- Stromal niche communalities underscore the contribution of the matricellular protein SPARC to B-cell development and lymphoid malignancies
- (2014) Sabina Sangaletti et al. OncoImmunology
- PD-L1 Expression Is Characteristic of a Subset of Aggressive B-cell Lymphomas and Virus-Associated Malignancies
- (2013) B. J. Chen et al. CLINICAL CANCER RESEARCH
- Diagnostic and Prognostic Utility of PD-1 In B Cell Lymphomas
- (2013) S. Muenst et al. DISEASE MARKERS
- A new biologic prognostic model based on immunohistochemistry predicts survival in patients with diffuse large B-cell lymphoma
- (2012) A. M. Perry et al. BLOOD
- Mesenchymal stromal cells orchestrate follicular lymphoma cell niche through the CCL2-dependent recruitment and polarization of monocytes
- (2012) F. Guilloton et al. BLOOD
- Interleukin-6 signaling regulates anchorage-independent growth, proliferation, adhesion and invasion in human ovarian cancer cells
- (2012) Yue Wang et al. CYTOKINE
- Discovery and prioritization of somatic mutations in diffuse large B-cell lymphoma (DLBCL) by whole-exome sequencing
- (2012) J. G. Lohr et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Combined Genetic Inactivation of β2-Microglobulin and CD58 Reveals Frequent Escape from Immune Recognition in Diffuse Large B Cell Lymphoma
- (2011) Madhavi Challa-Malladi et al. CANCER CELL
- Programmed Death Ligand 1 Is Expressed by Non-Hodgkin Lymphomas and Inhibits the Activity of Tumor-Associated T Cells
- (2011) D. J. Andorsky et al. CLINICAL CANCER RESEARCH
- High microvessel density determines a poor outcome in patients with diffuse large B-cell lymphoma treated with rituximab plus chemotherapy
- (2011) T. M. Cardesa-Salzmann et al. HAEMATOLOGICA
- Tumour-associated macrophages in diffuse large B-cell lymphoma: a study of the Osaka Lymphoma Study Group
- (2011) Naoki Wada et al. HISTOPATHOLOGY
- High expression of tumor-infiltrating macrophages correlates with poor prognosis in patients with diffuse large B-cell lymphoma
- (2011) Qi-chun Cai et al. MEDICAL ONCOLOGY
- MHC class II transactivator CIITA is a recurrent gene fusion partner in lymphoid cancers
- (2011) Christian Steidl et al. NATURE
- Analysis of the coding genome of diffuse large B-cell lymphoma
- (2011) Laura Pasqualucci et al. NATURE GENETICS
- The Stromal Cell Marker SPARC Predicts for Survival in Patients With Diffuse Large B-Cell Lymphoma Treated With Rituximab
- (2010) Paul N. Meyer et al. AMERICAN JOURNAL OF CLINICAL PATHOLOGY
- Interleukin-6 in bone metastasis and cancer progression
- (2010) Tasnim Ara et al. EUROPEAN JOURNAL OF CANCER
- Chronic active B-cell-receptor signalling in diffuse large B-cell lymphoma
- (2010) R. Eric Davis et al. NATURE
- Somatic mutations altering EZH2 (Tyr641) in follicular and diffuse large B-cell lymphomas of germinal-center origin
- (2010) Ryan D Morin et al. NATURE GENETICS
- A Stiff Blow from the Stroma: Collagen Crosslinking Drives Tumor Progression
- (2009) Mei Rosa Ng et al. CANCER CELL
- A New Immunostain Algorithm Classifies Diffuse Large B-Cell Lymphoma into Molecular Subtypes with High Accuracy
- (2009) W. W.L. Choi et al. CLINICAL CANCER RESEARCH
- Mutations of multiple genes cause deregulation of NF-κB in diffuse large B-cell lymphoma
- (2009) Mara Compagno et al. NATURE
- Modulation of matrix remodeling by SPARC in neoplastic progression
- (2009) Alexandre Chlenski et al. SEMINARS IN CELL & DEVELOPMENTAL BIOLOGY
- PD-1 and Its Ligands in Tolerance and Immunity
- (2008) Mary E. Keir et al. Annual Review of Immunology
- Correlation of high numbers of intratumoral FOXP3+ regulatory T cells with improved survival in germinal center-like diffuse large B-cell lymphoma, follicular lymphoma and classical Hodgkin's lymphoma
- (2008) A. Tzankov et al. HAEMATOLOGICA
- Prognostic impact of tumor infiltrating FOXP3 positive regulatory T cells in diffuse large B-cell lymphoma at diagnosis
- (2008) Na-Ri Lee et al. LEUKEMIA & LYMPHOMA
- Stromal Gene Signatures in Large-B-Cell Lymphomas
- (2008) G. Lenz et al. NEW ENGLAND JOURNAL OF MEDICINE
- Expression of CD68 tumor-associated macrophages in patients with diffuse large B-cell lymphoma and its relation to prognosis
- (2008) Sverker Hasselblom et al. PATHOLOGY INTERNATIONAL
- Molecular subtypes of diffuse large B-cell lymphoma arise by distinct genetic pathways
- (2008) G. Lenz et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
Add your recorded webinar
Do you already have a recorded webinar? Grow your audience and get more views by easily listing your recording on Peeref.
Upload NowCreate your own webinar
Interested in hosting your own webinar? Check the schedule and propose your idea to the Peeref Content Team.
Create Now